课题基金 / 基金详情

Functional Analysis of PGC1-a holo-complex in Diabetes

Functional Analysis of PGC1-a holo-complex in Diabetes
PGC1-a 全复合物在糖尿病中的功能分析
批准号:
6912253
负责人:
Marcus P Cooper
金额:
$13.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-05-01 至 2010-04-30

项目摘要

项目成果

Marcus P Cooper的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant): This proposal details a 5-year training program and is designed to prepare the principal investigator for a career in academic medicine. The principal investigator has fulfilled clinical requirements for internal medicine at the Johns Hopkins Hospital and cardiology fellowship at Brigham and Women's Hospital. The program encourages the acquisition of sound principles and expertise for studying the transcriptional co-activator, PPAR gamma co-activator 1 alpha (PGC1-alpha), as it pertains to metabolism. Bruce M. Spiegelman, Ph.D. is a pioneer in the field of energy metabolism and will mentor the principal investigator by providing career and scientific guidance. The research endeavors to elucidate the role of the PGC1-alpha holo-complex in diabetes and energy metabolism. Prior genetic studies in the laboratory identified several transcription factors regulated by PGC1- alpha and highlighted the pivotal role of PGC1-alpha in energy homeostasis. The proteome is the final determinant of cellular phenotype, and we hypothesize that characterization of the PGC1-alpha holo-complex will identify novel factors that regulate diabetes and energy metabolism. Specific aims of the project are: 1) Establish a versatile technique to isolate PGC1-alpha holo-complexes. 2) Elucidate the proteins comprising the PGC1-alpha holo-complex from normal and diabetic tissues. 3) Characterize the molecular and biological significance of the PGC1-alpha complex. This study constitutes the first functional and proteomic analysis of the PGC1-alpha holo-complex, and may define new regulatory roles for PGC1-alpha in diabetes. The department of Cancer Biology at the Dana-Farber Cancer Institute provides a stimulating and scientifically sound base from which the principal investigator can build a career in academic medicine. Ultimately, the environment and the program will foster the development of the principal investigator into an independent physician-scientist.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms and metabolic implications of LRP130 in NAFLD
Mechanisms and metabolic implications of LRP130 in NAFLD
Mechanisms and metabolic implications of LRP130 in NAFLD
Mechanisms and metabolic implications of LRP130 in NAFLD
海外基金